mstockstill on DSKH9S0YB1PROD with NOTICES


Federal Register / Vol. 74, No. 230 / Wednesday, December 2, 2009 / Notices 63153 

accompanied, the canceled product. The 

order will specifically prohibit any use 

of existing stocks that is not consistent 

with such previously approved labeling. 

If, as the Agency currently intends, the 

final cancellation order contains the 

existing stocks provision just described, 

the order will be sent only to the 

affected registrants of the canceled 

products. If the Agency determines that 

the final cancellation order should 

contain existing stocks provisions 

different than the ones just described, 

the Agency will publish the cancellation 

order in the Federal Register. 

List of Subjects 

Environmental protection, Pesticides 

and pests. 

Dated: November 19,2009. 

Richard P. Keigwin, Jr., 

Director, Pesticide Re-evaluation Division, 

Office of Pesticide Programs. 

[FR Doc. E9–28542 Filed 12–1–09; 8:45 am] 

BILLING CODE 6560–50–S 

FEDERAL ELECTION COMMISSION 

Sunshine Act Notices 

AGENCY: Federal Election Commission. 

DATE AND TIME: Tuesday, December 1, 


2009, at 10 a.m. 


PLACE: 999 E Street, NW., Washington, 


DC. 


STATUS: This meeting will be closed to 


the public. 


ITEMS TO BE DISCUSSED: 

Compliance matters pursuant to 2 

U.S.C. 437g. 

Audits conducted pursuant to 2 

U.S.C. 437g, 438(b), and Title 26, U.S.C. 

Matters concerning participation in 

civil actions or proceedings or 

arbitration. 

Internal personnel rules and 

procedures or matters affecting a 

particular employee. 

PERSON TO CONTACT FOR INFORMATION: 

Judith Ingram, Press Officer, Telephone: 

(202) 694–1220. 

Mary W. Dove, 

Secretary of the Commission. 

[FR Doc. E9–28705 Filed 12–1–09; 8:45 am] 

BILLING CODE 6715–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Determination Concerning a Petition 

To Add a Class of Employees to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 


Human Services (HHS). 


ACTION: Notice. 


SUMMARY: HHS gives notice of a 

determination concerning a petition to 

add a class of employees at the BakerPerkins Company, Saginaw, Michigan, 

to the Special Exposure Cohort (SEC) 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 (EEOICPA), 42 

U.S.C. 7384q. On November 13, 2009, 

the Secretary of HHS determined that 

the following class of employees does 

not meet the statutory criteria for 

addition to the SEC as authorized under 

EEOICPA: 

All AWE employees who performed 

Atomic Energy Commission work at Baker 

Perkins Company, in Saginaw, Michigan, 

from May 14, 1956 through May 18, 1956. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Interim Director, 

Office of Compensation Analysis and 

Support, National Institute for 

Occupational Safety and Health 

(NIOSH), 4676 Columbia Parkway, MS 

C–46, Cincinnati, OH 45226, Telephone 

513–533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. E9–28809 Filed 12–1–09; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

and the Assistant Secretary for Health 

have taken final action in the following 

case: 

Rashanda Robertson, Emory 

University: Based on an assessment 

conducted by Emory University (EU), 

the Respondent’s own admission, and 

additional oversight of that admission 

conducted by ORI, ORI and EU found 

that Ms. Rashanda Robertson, former 

Research Coordinator, Department of 

General Medicine, EU, engaged in 

research misconduct in research 

supported by National Heart, Lung, and 

Blood Institute (NHLBI), National 

Institutes of Health (NIH), grant K23 

HL077597. The randomized study for 

which she coordinated was designed to 

assess whether patient medication 

compliance was improved by a meeting 

with a clinical pharmacist to discuss the 

patient’s current and newly prescribed 

medications prior to the patient’s 

discharge from the hospital. The 

enrolled subjects randomized to the 

intervention group received a card 

listing all of their medications and a 

‘‘pill box’’ to help them with medication 

compliance. The subjects also were 

called three days after discharge to 

check on their medication compliance. 

Specifically, the U.S. Public Health 

Service (PHS), EU, and Ms. Robertson, 

in a three-way Voluntary Settlement 

Agreement, agree that the Respondent 

committed the following acts of research 

misconduct, which she fully 

acknowledged. In an affidavit obtained 

by EU, the Respondent admitted that 

during the last two weeks of her 

employment at EU, she fabricated 

enrollment forms to create enrollees 

who did not exist and falsified the data 

of some enrollees who did not exist to 

cover up the data fabrication. To create 

the fabricated enrollment forms, the 

Respondent: 

• Identified patients who were 

eligible for the study based on their 

charge screens but who were considered 

ineligible after a face-to-face screen; 

• Obtained patients’ names from the 

screening records and used the names to 

obtain the personal information (address 

and telephone numbers) on these 

patients from the site hospital’s 

pharmacy online system;

• Created a fabricated enrollment 

form for each of the non-existent 

enrollees; specifically, Respondent 

fabricated a participant’s name by using 

the name of a patient who had failed 

screening and then fabricated the date of 

enrollment by using the date of the 

patient’s screening failure; using this 

method, Respondent fabricated the 

participant names, personal 

information, and enrollment dates on 

twenty-eight (28) enrollment forms; 

• Dispersed the fabricated enrollment 

forms among those enrollment forms, 

beginning around participant number 

136 through 212;

• Falsified the numbering of the 

enrollment forms for some individuals 

who had actually been enrolled to 

disperse the fabricated enrollment forms 

among the authentic enrollment forms; 

Respondent falsified the status of some 

actual participants to include them in 

the intervention group, even though 

they had not actually received the 

intervention; Respondent falsified the 

data on both the enrollment form and 

the follow-up form for 16 participants 

between numbers 137 and 198;